Table 2

Procedure Time

Procedure and outcomeAll patients, (n=58)Isolated M2 or M3 (n=31)LVO+M2 or M3 (n=27)Difference (95% CI)* p Value
Time from symptom onset to groin puncture (median, IQR), min105 (95–120)105 (95–125)110 (95–120)0 (−10 to 10)0.9563
Time from symptom onset to recanalization (median, IQR), min130 (115–145)127.5 (115–145)130 (115–150)0 (−15 to 10)0.6646
Procedure duration (median, IQR), min54.3 (37–65)45.3 (30–55)63.5 (45–75)−22 (−40 to 5)0.014
Post-treatment mTICI score 2b–3 (n/N (%)), per core laboratory58/58 (100%)31/31 (100%)27/27 (100%)0%, N/A1.0000
Post-treatment mTICI score 2b–3 (n/N (%)), per site PI53/58 (91.4%)28/31 (90.3%)25/27 (92.6%)−2.3% (−27.4% to 23.4%)1.0000
Post-treatment mTICI score 3 (n/N (%)), per core laboratory48/58 (82.8%)24/31 (77.4%)24/27 (88.9%)−11.5% (−36.4% to 14.1%)0.3110
Post-treatment mTICI score 3 (n/N (%)), per site PI41/58 (70.7%)22/31 (71.0%)19/27 (70.4%)1.0% (−25.0% to 26.1%)1.0000
Post-treatment NIHSS score (median, IQR)4 (3–6)4 (3–5)5 (3–7)−1 (−2 to 0)0.1909
Good functional outcome at discharge, mRS 0–2 (n/N (%))54/58 (93.1%)29/31 (93.5%)25/27 (92.6%)1.0% (−24.3% to 26.5%)1.0000
Good functional outcome at 90 days, mRS 0–2 (n/N (%))55/58 (94.8%)30/31 (96.8%)25/27 (92.6%)4.2% (−21.3% to 29.6%)0.5931
Symptomatic ICH (n/N (%))2/58 (3.4%)0/31 (0%)2/27 (7.4%)−7.4% (−32.6% to 18.3%)0.2123
Asymptomatic ICH (n/N (%))10/58 (17.2%)2/31 (6.5%)8/27 (29.6%)−23.2% (−46.6% to 3.0%)0.0340
Vessel dissection (n/N (%))0/58 (0%)0/31 (0%)0/27 (0%)0%, N/A1.000
Vessel perforation (n/N (%))0/58 (0%)0/31 (0%)0/27 (0%)0%, N/A1.000
Major groin complication (n/N (%))0/58 (0%)0/31 (0%)0/27 (0%)0%, N/A1.000
  • *Wilcoxon rank sum or Fisher’s exact test for difference between isolated M2 or M3 and LVO + M2 or M3 groups. Hodges-Lehmann estimate and CI was computed for results of Wilcoxon rank sum test. Exact estimate and Clopper-Pearson CI was computed for results of Fisher’s exact test.

  • ICH, intracranial hemorrhage; LVO, large vessel occlusion; mRS, modified Rankin Scale; mTICI, modified Thrombolysis in Cerebral Infarction; NIHSS, National Institutes of Health Stroke Scale; PI,Principal Investigator.